Achondroplasia: genes and variants

Achondroplasia is linked to 1 analyzed protein (FGFR3). 9 DNA variants are known to cause it; 17 more are uncertain, and 0 of those already look disease-causing on computable evidence.

Last updated 2026-09-30. Research information, not medical advice.

Genes linked to Achondroplasia

Where Achondroplasia variants cluster

Known disease-causing variants in Achondroplasia

VariantPositionProtein partClinical label
FGFR3 K650T650Protein kinaseDisease-causing (★★)
FGFR3 S279C279Ig-like C2-type 3Disease-causing (★★)
FGFR3 S344C344Ig-like C2-type 3Disease-causing (★★)
FGFR3 P250R250ExtracellularDisease-causing (★★)
FGFR3 Y373C373ExtracellularDisease-causing (★★)
FGFR3 G382S382TransmembraneDisease-causing (★)
FGFR3 L395I395TransmembraneDisease-causing (★)
FGFR3 G380R380TransmembraneDisease-causing
FGFR3 L377R377TransmembraneDisease-causing

Which prediction tools work for Achondroplasia

How often each tool ranks a disease-causing variant above a harmless one (AUROC × 100).

Same protein, different disease

Diseases related to Achondroplasia

Frequently asked questions

Which genes are linked to Achondroplasia?

In CATVariant, Achondroplasia is linked to 1 analyzed protein: FGFR3 (Fibroblast growth factor receptor 3).

How many genetic variants are linked to Achondroplasia?

34 variants: 9 are classified as disease-causing (pathogenic or likely pathogenic) in ClinVar and 17 are of uncertain significance or have conflicting reports.

Which uncertain variants in Achondroplasia look disease-causing?

None of the uncertain variants currently reaches the likely-pathogenic range on computable evidence alone.

Which variant effect predictor works best for Achondroplasia?

Among tools not trained on clinical labels, SIFT separates this disease's known disease-causing variants from harmless ones best (AUROC 0.84, based on 9 disease-causing and 26 harmless variants).

About this data

Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from the latest public CATVariant analysis of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.

Download every variant as CSV · Browse all diseases · Methods · About the Center